NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fluor and certain of its officers and/or directors […]
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ:BMBL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bumble and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fortinet and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PubMatic, Inc.("PubMatic" or the "Company") (NASDAQ:PUBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PubMatic and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against KinderCare Learning Companies, Inc.("KinderCare" or the "Company") (NYSE:KLC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
The globalBiobanking Market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc.("Replimune" or the "Company") (NASDAQ:REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ:RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Flywire Corporation ("Flywire" or the "Company") (NASDAQ:FLYW) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-04110, is